OTC DFL ‘Remains Static, Non-Customizable Tool’ As US FDA Lifts Curtain On Potential Changes

 
• By Malcolm Spicer
  
In an FDA webinar slide, California State University, Sacramento, marketing researcher Jesse Catlin captured the consensus about OTC DFLs required by the agency. • Source: Jesse Catlin/FDA webinar

More from Regulation

More from Policy & Regulation